May 24, 2026 a 08:38 pm
DGX: Analysts Ratings - Quest Diagnostics Incorporated
The recent analyst ratings for Quest Diagnostics Incorporated (DGX) indicate a stable outlook, highlighted by a majority leaning towards 'Hold' with low occurrences of 'Sell'. The company's solid foundation in providing diagnostic and information services supports this optimism. However, the moderate count of 'Buy' ratings suggests cautious investor sentiment, potentially reflecting market restraint amid broader economic conditions.
Historical Stock Grades
For May 2026, the distribution of ratings is as follows:
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 2 | |
| Buy | 7 | |
| Hold | 9 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Over recent months, the sentiment for DGX has shown noticeable stability, particularly in 'Hold' ratings, reflecting market confidence. The persistence in 'Buy' ratings underscores this sentiment, while zero 'Sell' mentions signify minimal negative sentiment.
- The 'Strong Buy' category remains constant, indicating a sustained high confidence level from a few analysts.
- 'Buy' ratings have seen a steady count, revealing consistency in positive outlook.
- 'Hold' remains the majority stance, highlighting cautious yet favorable long-term projections.
Percentage Trends
The distribution of ratings for DGX over the recent months displays minor but notable shifts in sentiment:
- The percentage for 'Strong Buy' held constant around 6-7%, reflecting unwavering confidence among certain analysts.
- 'Buy' ratings dominated approximately 25%, indicating moderate growth potential expectations.
- 'Hold' constituted nearly 50%, showing general consensus towards stable market performance.
Throughout the last year, there's been a subtle reduction in 'Strong Buy' ratings, while 'Hold' has remained prevalent, suggesting a cautious yet stable outlook.
Latest Analyst Recommendations
Recent analyst activity for DGX reflects consistent sentiments without significant alterations in outlook. The past ratings indicate open-mindedness towards maintaining current valuations:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2026-04-22 | Neutral | Neutral | Baird |
| 2026-04-22 | Overweight | Overweight | Barclays |
| 2026-04-22 | Hold | Hold | Truist Securities |
| 2026-04-22 | Neutral | Neutral | UBS |
| 2026-04-08 | In Line | In Line | Evercore ISI Group |
Analyst Recommendations with Change of Opinion
In the context of shifts in opinion, there have been a few key adjustments, emphasizing evolving market perspectives:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-25 | Neutral | Outperform | Baird |
| 2025-03-04 | Neutral | Buy | Citigroup |
| 2025-01-06 | Outperform | Market Perform | Leerink Partners |
| 2024-12-17 | Overweight | Equal Weight | Morgan Stanley |
| 2024-10-23 | Outperform | Neutral | Baird |
Interpretation
The overall trends and current ratings suggest a balanced market view towards Quest Diagnostics. Analysts appear to favor a 'Hold' rating, indicating a cautious yet stable outlook amidst existing market dynamics. The minimal presence of negative ratings reflects sustained confidence in the company's long-term potential, although the slight decline in 'Strong Buy' ratings may point to emerging market uncertainties.
The stability of the ratings suggests moderate analyst consensus without significant swings, indicating a relatively steady market expectation for DGX.
Conclusion
The analysis of Quest Diagnostics Incorporated reveals a predominantly stable sentiment, with the majority of analysts opting for a 'Hold' stance. The consistent presence of 'Buy' ratings, despite the absence of 'Sell' and 'Strong Sell' opinions, underscores a solid, if cautious, market confidence. However, the declination in 'Strong Buy' ratings intimates potential concern amidst broader economic climates, compelling a careful approach. For stakeholders, this highlights opportunities rooted in lasting market presence while succinctly weighing existing and forthcoming market variables. In conclusion, the stock remains a pivotal player with stable strategies, though continuous monitoring is advised to adapt to sector developments.
Smart Data Insight
Master the Perfect Entry & Exit for this Stock
Don't leave your profits to chance. Historically, this stock follows specific seasonal patterns that institutional traders use to maximize returns.
- ✅ Identify the "Golden Buying Window"
- ✅ Avoid high-risk correction cycles
- ✅ Backtested data from the last 20+ years